XK and chronic hepatitis B virus infection: Moreover, there has been controversy over the necessity of antiviral treatment for immunotolerant phase CHB patients, and the present study provides a new perspective for considering early NA treatment and reducing viral antigen load with RNAi in chronic hepatitis B patients (40, 41).